... thickness; BCVA, best-corrected visual acuity; COST, cone outer segment tip; EZ, ellipsoid zone. Branch retinal vein occlusion Bevacizumab Optical coherence tomography Response Macular edema Retinal vein occlusion (RVO) is one of the most common retinal vascular diseases, and macular...

... were kept on maintenance therapy; 1 recurred and 5 did not develop recurrence. One patient was taken off of maintenance therapy and later developed recurrent macular hole requiring macular hole surgery. Conclusions: Medical therapy to decrease macular edema may facilitate macular hole closure...

...) integrity in treatment-naïve patients with macular edema (ME) secondary to retinal vascular disease (RVD). Methods: This is a retrospective study conducted on patients with ME secondary to RVD, who underwent a DEX implant. Results: One-hundred eyes were included. Mean age was 70.3 ± 11.1 years. Mean ELM...

...Ozlem Dikmetas; Laura Kuehlewein; Faik Gelisken Introduction: The aim of this article was to report on a rebound phenomenon after intravitreal triamcinolone acetonide (IVTA) injection for macular edema secondary to diabetic retinopathy (DR) and central or branch retinal vein occlusion (CRVO/BRVO...

... vein occlusion (CRVO)-related macular edema in patients with and without systemic hypertension (HT) to assess the influence of repeated anti-VEGF therapy and HT on the choroid in CRVO eyes. Methods: We conducted a retrospective study involving 27 patients with CRVO-related macular edema from January...

...Ender Sırakaya; Bekir Küçük; Alperen Ağadayı Purpose: The aim of this study was to compare responses to aflibercept treatment in age-based groups of patients with macular edema following branch retinal vein occlusion (BRVO). Methods: Eighty-five patients with macular edema following BRVO were...

..., instructions or products referred to in the content or advertisements. Retinal vein occlusion Macular edema Guidelines Disease management Retinal vein occlusion (RVO) is among the leading causes of visual impairment and is often due to an underlying systemic disease. Advances in imaging...

...Irini Chatziralli; Eleni Dimitriou; George Theodossiadis; Alexandros Chatzirallis; Dimitrios Kazantzis; Panagiotis Theodossiadis Purpose: The aim of this study was to investigate the efficacy and safety of intravitreal dexamethasone implant for the treatment of macular edema after pars plana...

...Young Hee Yoon; Jong Woo Kim; Joo Yong Lee; In Taek Kim; Se Woong Kang; Hyeong Gon Yu; Hyoung Jun Koh; Sung Soo Kim; Dong-Jin Chang; Susan Simonyi Purpose: To evaluate the effect of dexamethasone intravitreal implant for macular edema (ME) following branch retinal vein occlusion (BRVO) in Korean...

...Donghyoun Noh; Gahyung Ryu; Junyeop Lee; Min Sagong Purpose: To evaluate whether early anatomical and visual acuity (VA) responses to intravitreal bevacizumab (IVB) in macular edema secondary to branch retinal vein occlusion (BRVO) are associated with 1-year follow-up outcomes. Methods: Ninety-nine...

...) agent followed by pro re nata (PRN) dosing with that of 3 initial monthly injections followed by PRN dosing in patients with macular edema (ME) after central retinal vein occlusion (CRVO). Methods: Twenty-nine eyes received 1 initial injection (1+PRN group) and 20 received 3 monthly injections (3+PRN...

...Marion R. Munk; Joel Lincke; Helena Giannakaki-Zimmermann; Andreas Ebneter; Sebastian Wolf; Martin S. Zinkernagel Purpose: To compare conventional 30° spectral domain optical coherence tomography (SD-OCT) with 55° wide-field SD-OCT for the assessment of diabetic macular edema (DME). Methods...

... there is an alteration of the inner blood-retinal barrier (BRB). Fig. 2. Schematic drawing of the retina indicating how increased blood pressure may play a role in retinal edema when there is an alteration of the inner blood-retinal barrier (BRB). Macular edema Retinal edema Blood-retinal barrier...

... with macular edema (ME) resolution after retinal vein occlusion. Methods: Patients with ME after retinal vein occlusion, receiving Ozurdex®, were included to assess the following endpoints: visual acuity and central retinal thickness, retreatment, number of injections, side effects and ME resolution. ME...

...Hidetaka Noma; Tatsuya Mimura; Kanako Yasuda; Hayate Nakagawa; Ryosuke Motohashi; Osamu Kotake; Masahiko Shimura The aqueous humor levels of cytokines and growth/inflammatory factors were measured in 46 branch retinal vein occlusion (BRVO) patients with macular edema (ME) who were treated...

...Jong Chan Im; Jae Pil Shin; In Taek Kim; Dong Ho Park Purpose: The aim of this study was to evaluate the effect of intravitreal dexamethasone implant fragmentation on clinical outcomes in branch retinal vein occlusion (BRVO)-induced macular edema (ME). Methods: All consecutive patients receiving...

...) following anti-vascular endothelial growth factor (anti-VEGF) therapy for the treatment of macular edema secondary to central retinal vein occlusion (CRVO). Methods: Eighteen eyes were treated with intravitreal aflibercept (IVA), and 5 were treated with intravitreal ranibizumab (IVR). Fundus photographs...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Ischemia Macular edema Diabetic macular edema Dear Editor...

...Emilia Maggio; Antonio Polito; Massimo Guerriero; Grazia Pertile Purpose: To evaluate anatomical and visual outcomes following intravitreal dexamethasone implantation (Ozurdex) in eyes with visual loss due to macular edema (ME) secondary to retinal vein occlusion (RVO) and to identify predictive...

... vein occlusion Central retinal vein occlusion Branch retinal vein occlusion Ranibizumab Dexamethasone implant Macular edema Anti-VEGF therapy Retinal vein occlusion (RVO) is the second most common vascular retinopathy after diabetic retinopathy [ 1,2 ]. Branch retinal vein occlusion...